The novel approach of tirzepatide peptide represents a significant advance in the management of type 2 diabetes. Different to existing drugs, tirzepatide targets multiple pathways – GLP-1 and GIP – leading to greater sugar control and potential weight loss. Researchers are exploring its long-term